COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,642 Articles (22,913 medRxiv, 8,729 bioRxiv)

Most recent first Previous |  Page 2932: Articles 29311-29320  | Next

Disparate temperature-dependent virus - host dynamics for SARS-CoV-2 and SARS-CoV in the human respiratory epithelium
V'kovski, P., Steiner, S., Gultom, M., Kelly, J. N., Russeil, J., Mangeat, B., Cora, E., Pezoldt, J., Holwerda, M., Kratzel, A., Laloli, L., Wider, M., Portmann, J., Thao, T. T. N., Ebert, N., Stalder, H., Hartmann, R., Gardeux, V., Alpern, D., Deplancke, B., Thiel, V., Dijkman, R.
10.1101/2020.04.27.062315 — Posted: 2020-04-27 Discussion: Onsite
Structure of replicating SARS-CoV-2 polymerase
Hillen, H. S., Kokic, G., Farnung, L., Dienemann, C., Tegunov, D., Cramer, P.
10.1101/2020.04.27.063180 — Posted: 2020-04-27
Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice.
Pruijssers, A. J., George, A. S., Schäfer, A., Leist, S. R., Gralinski, L. E., Dinnon, K. H., Yount, B. L., Agostini, M. L., Stevens, L. J., Chappell, J. D., Lu, X., Hughes, T. M., Gully, K. L., Martinez, D. R., Brown, A. J., Graham, R. L., Perry, J. K., Du Pont, V., Pitts, J., Ma, B., Babusis, D., Murakami, E., Feng, J. Y., Bilello, J. P., Porter, D. P., Cihlar, T., Baric, R. S., Denison, M. R., Sheahan, T. P.
10.1101/2020.04.27.064279 — Posted: 2020-04-27 Discussion: Onsite
A SARS-CoV-2 vaccine candidate would likely match all currently circulating strains
Dearlove, B. L., Lewitus, E., Bai, H., Li, Y., Reeves, D. B., Joyce, M. G., Scott, P., Amare, M., Vasan, S., Michael, N. L., Modjarrad, K., Rolland, M.
10.1101/2020.04.27.064774 — Posted: 2020-04-27
SARS-CoV-2 On-the-Spot Virus Detection Directly From Patients
Ben-Assa, N., Naddaf, R., Gefen, T., Capucha, T., Hajjo, H., Mandelbaum, N., Elbaum, L., Rogov, P., King, D. A., Kaplan, S., Rotem, A., Chowers, M., Szwarcwort-Cohen, M., Paul, M., Geva-Zatorsky, N.
10.1101/2020.04.22.20072389 — Posted: 2020-04-27 Discussion: Onsite
Cytotoxicity evaluation of chloroquine and hydroxychloroquine in multiple cell lines and tissues by dynamic imaging system and PBPK model
Yang, J., Wu, M., Liu, X., Liu, Q., Guo, Z., Yao, X., Liu, Y., Cui, C., Li, H., Song, C., Liu, D., Xue, L.
10.1101/2020.04.22.056762 — Posted: 2020-04-27 Discussion: Offsite
COVID-19 in Iran: A Deeper Look Into The Future
Kafieh, R., Arian, R., Saeedizadeh, N., Minaee, S., amini, z., Kumar Yadav, S., Vaezi, A., Rezaei, N., Haghjooy Javanmard, S.
10.1101/2020.04.24.20078477 — Posted: 2020-04-27
Smart Pooled sample Testing for COVID-19: A Possible Solution for Sparsity of Test Kits
Bukhari, S. U. K., Khalid, S. S., Syed, A., Shah, S. S. H.
10.1101/2020.04.21.20044594 — Posted: 2020-04-27
Early detection of superspreaders by mass group pool testing can mitigate COVID-19 pandemic
Gongalsky, M. B.
10.1101/2020.04.22.20076166 — Posted: 2020-04-27 Discussion: Onsite
A poor-man's approach to the effective reproduction number: the COVID-19 case
Menendez, J.
10.1101/2020.04.22.20076430 — Posted: 2020-04-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).